Stockreport

Global Vaccine Market Analysis & Forecast (2018-2028): A $103.57 Billion Opportunity, Growing at a CAGR of 11.02%

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
PDF Dublin, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The "Global Vaccine Market: Focus on Product Type (Next-Generation Vaccine), Route of Administration, Disease Type, 22 Co [Read more]